Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech, genomics and diagnostics company, today announced positive preliminary results from ...
UNIONDALE, NY, Sept. 03, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today ...
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might ...
UNIONDALE, NY, June 06, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced the ...
UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that ...
This is a preview. Log in through your library . Abstract Effects of x-ray exposures ranging from 32 to 1024 R on mitosis in chick, mouse, and rat fibroblasts, mouse mammary carcinoma (LH5), Walker ...
ProPhase Labs (PRPH) filed a definitive proxy statement with the U.S. Securities and Exchange Commission on Friday, August 15, 2025 and received a “no further comments” letter from the SEC’s Division ...
UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced ...
Diagnostics and genomics company ProPhase Labs is building a genomics lab as part of an effort to expand its in-house clinical and genomics testing capabilities. The company said June 13 that it has ...
UNIONDALE, NY, Aug. 11, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today ...
ProPhase Labs Inc (NASDAQ:PRPH) has made significant cost reductions, including reducing headcount from 96 to 25 employees, which will lower overhead expenses. The company has a promising esophageal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback